VolteFace Policy Director, Dr Henry Fisher, will be speaking to us on "Altering the State: An innovative drug market needs innovative policy solutions". Henry has a DPhil in Pharmaceutical Chemistry and has worked previously with the Beckley Foundation, a drug policy reform think tank.
The prohibition placed on the drug market since the mid-20th century has led to perverse incentives in the multibillion pound industry, increasing the potency of the drugs available, restricting choice, and leading to the creation of new unknown, untested, and sometimes dangerous new psychoactive substances.
Most government policy changes have built upon prohibition. To move forward, we need to understand what drives those acting in these markets, whether legal or illegal, and create policies that incentivise best practice and innovation that supports wider civil society and public health goals.